319 related articles for article (PubMed ID: 30917849)
1. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
Byun HK; Kim N; Yoon HI; Kang SG; Kim SH; Cho J; Baek JG; Chang JH; Suh CO
Radiat Oncol; 2019 Mar; 14(1):51. PubMed ID: 30917849
[TBL] [Abstract][Full Text] [Related]
2. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma.
Huang J; DeWees TA; Badiyan SN; Speirs CK; Mullen DF; Fergus S; Tran DD; Linette G; Campian JL; Chicoine MR; Kim AH; Dunn G; Simpson JR; Robinson CG
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1000-1007. PubMed ID: 26025775
[TBL] [Abstract][Full Text] [Related]
4. Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.
Mendez JS; Govindan A; Leong J; Gao F; Huang J; Campian JL
J Neurooncol; 2016 Apr; 127(2):329-35. PubMed ID: 26725885
[TBL] [Abstract][Full Text] [Related]
5. Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients.
Hui CY; Rudra S; Ma S; Campian JL; Huang J
J Neurooncol; 2019 May; 143(1):129-136. PubMed ID: 30864102
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience.
Zhong L; Chen L; Lv S; Li Q; Chen G; Luo W; Zhou P; Li G
Radiat Oncol; 2019 Jun; 14(1):104. PubMed ID: 31196126
[TBL] [Abstract][Full Text] [Related]
7. Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma.
Kim WJ; Dho YS; Ock CY; Kim JW; Choi SH; Lee ST; Kim IH; Kim TM; Park CK
J Neurooncol; 2019 Jun; 143(2):321-328. PubMed ID: 30982199
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
9. Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.
Thibouw D; Truc G; Bertaut A; Chevalier C; Aubignac L; Mirjolet C
J Neurooncol; 2018 Apr; 137(2):429-438. PubMed ID: 29374810
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
11. Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer.
Prasad S; Cambridge L; Huguet F; Chou JF; Zhang Z; Wu AJ; O'Reilly EM; Allen PJ; Goodman KA
Pract Radiat Oncol; 2016; 6(2):78-85. PubMed ID: 26577010
[TBL] [Abstract][Full Text] [Related]
12. Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma.
Byun HK; Kim N; Park S; Seong J
Strahlenther Onkol; 2019 Nov; 195(11):1007-1017. PubMed ID: 30989242
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.
Koerber SA; Slynko A; Haefner MF; Krug D; Schoneweg C; Kessel K; Kopp-Schneider A; Herfarth K; Debus J; Sterzing F
Radiat Oncol; 2014 May; 9():113. PubMed ID: 24886574
[TBL] [Abstract][Full Text] [Related]
14. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
15. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme.
Chen YD; Feng J; Fang T; Yang M; Qiu XG; Jiang T
Chin Med J (Engl); 2013 Jun; 126(12):2320-4. PubMed ID: 23786946
[TBL] [Abstract][Full Text] [Related]
17. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.
Shiraishi Y; Fang P; Xu C; Song J; Krishnan S; Koay EJ; Mehran RJ; Hofstetter WL; Blum-Murphy M; Ajani JA; Komaki R; Minsky B; Mohan R; Hsu CC; Hobbs BP; Lin SH
Radiother Oncol; 2018 Jul; 128(1):154-160. PubMed ID: 29248170
[TBL] [Abstract][Full Text] [Related]
18. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database.
Blumenthal DT; Won M; Mehta MP; Gilbert MR; Brown PD; Bokstein F; Brachman DG; Werner-Wasik M; Hunter GK; Valeinis E; Hopkins K; Souhami L; Howard SP; Lieberman FS; Shrieve DC; Wendland MM; Robinson CG; Zhang P; Corn BW
Neuro Oncol; 2018 Jun; 20(7):966-974. PubMed ID: 29462493
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials.
Carlson JA; Reddy K; Gaspar LE; Ney D; Kavanagh BD; Damek D; Lillehei K; Chen C
J Neurooncol; 2015 Jun; 123(2):251-7. PubMed ID: 25920710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
